Last updated: May 11, 2014
Sponsor: Asker & Baerum Hospital
Overall Status: Completed
Phase
3
Condition
Chest Pain
Arrhythmia
Cardiac Disease
Treatment
N/AClinical Study ID
NCT00313157
2005-004221-26
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Persistent or permanent atrial fibrillation with ventricular rate > 80/min at restand/or > 100/min average at daytime.
Male or female, age > 18.
Exclusion
Exclusion Criteria:
Hypersensitivity or contraindication to metoprolol, verapamil, diltiazem orcarvedilol.
Coronary heart disease or heart failure
Systolic blood pressure < 100 mmHg
AV-conduction disturbance
Severe hepatic or renal dysfunction
Thyrotoxicosis
Ongoing treatment with Digitalis
Pregnancy or lactation
Study Design
Total Participants: 80
Study Start date:
April 01, 2006
Estimated Completion Date:
September 30, 2010
Study Description
Connect with a study center
Vestre Viken Hospital Trust, Baerum Hospital
Rud, Akershus 1309
NorwaySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.